anesthesia glp-1 news Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists It’s not because the GLP-1

Wheeler DC, Stefnsson BV, Jongs N, et al

Some of the more common ones include dizziness, headaches, breast tenderness, or changes in menstrual cycles

PMID: 40243461

Cardiovascular Safety : The cardiovascular safety of tirzepatide has been evaluated and confirmed to date through a pre-specified meta-analysis of phase 2 and 3 randomized trials comparing tirzepatide with other placebo, insulin glargine, degludec, semaglutide, dulaglutide for a minimum of 26 weeks (including the GPGB, SURPASS 1,2,3,4,5, and J-mono studies) [67]

Campana, L., Esser, H., Huch, M

At DripGym, we aim for transparency and help set realistic expectations for our clients, whose outcomes can vary based on several factors